You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,666,858


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,666,858
Title: UTILIZATION OF GON-4-ENE THERAPY IN TREATMENT OF FEMALES AND IN GROWTH STIMULATION
Abstract:Methods of using certain 13-ethyl-gon-4-enes are described, namely 13.beta.,17.alpha.-diethyl-17.beta.-hydroxygon-4-en-3-one, and the decanoate ester of 13.beta.-ethyl-17.beta.-hydroxygon-4-en-3-one for growth stimulation in mammals; and 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one, to treat dysfunctions of the female reproductive system in mammals, to control cyclic regularity, and to prevent conception in female mammals.
Inventor(s): Hughes; Gordon Alan (Haverford, PA), Smith; Herchel (Wayne, PA)
Assignee: SAID Smith, by said Hughes (N/A)
Application Number:04/649,800
Patent Claim Types:
see list of patent claims
Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 3,666,858: A Comprehensive Analysis

Introduction

United States Patent 3,666,858, though an older patent, provides valuable insights into the evolution of patent law and the criteria for patent eligibility. This analysis will delve into the scope and claims of this patent, as well as the broader patent landscape, to offer a detailed understanding of its significance and implications.

Background of the Patent

Patent 3,666,858 was granted in the early 1970s, a period marked by significant technological advancements. To understand its context, it is crucial to consider the patent laws and regulations in place at that time.

Claims and Scope

The patent's claims are the heart of its protection, defining what the inventor has created and what is protected. Here, we will analyze the specific claims made in the patent.

Claim Structure

The claims in Patent 3,666,858 would typically follow a specific structure, including:

  • Independent Claims: These define the broadest scope of the invention.
  • Dependent Claims: These narrow down the invention by adding additional limitations to the independent claims.

Subject Matter Eligibility

Even though the 2024 USPTO guidance update on AI patents did not exist at the time of this patent, the principles of subject matter eligibility remain relevant. The patent would need to meet the criteria of being a practical application rather than an abstract idea or mere data processing[1].

Patent Landscape Analysis

Patent landscape analysis is a critical tool for understanding the broader technological domain in which a patent exists.

Technological Domain

This involves identifying the specific field of technology to which the patent pertains. For example, if the patent is related to computer systems or medical devices, understanding the trends and developments in these fields is essential[3].

Competitor Analysis

Analyzing the patents held by competitors can reveal market trends, potential areas of innovation, and legal risks. This includes looking at the filing dates, application numbers, and legal status of patents in the same domain[3].

Market Developments

Patent landscape reports often include insights into market developments such as mergers and acquisitions, licensing activities, and litigation. These can indicate the commercial viability and strategic importance of the patented technology[3].

Legal Status and Expiry Dates

Understanding the legal status and expected expiry dates of patents is crucial for strategic planning.

Legal Status

The legal status (alive, pending, lapsed, revoked, or expired) of a patent affects its enforceability and the rights it confers. For Patent 3,666,858, determining its current legal status would be essential for any legal or business decisions[3].

Expected Expiry Dates

Knowing when a patent is expected to expire helps in planning for future innovations or potential licensing opportunities. The Uruguay Round Agreements Act (URAA) changed the patent term to 20 years from the effective filing date, which would be relevant for patents filed after 1995, but not directly applicable to this older patent[2].

Impact of Recent Patent Law Updates

While the 2024 USPTO guidance update on AI patents is recent and does not directly apply to Patent 3,666,858, it highlights the evolving nature of patent law.

AI-Assisted Inventions

The update clarifies that the use of AI in developing an invention does not affect its subject matter eligibility. This distinction ensures that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution[1].

Practical Applications

The update emphasizes the importance of integrating judicial exceptions into practical applications. This means that claims must demonstrate tangible benefits and solve specific problems in the relevant field to be considered patent-eligible[1].

Case Law and Precedents

Case law and precedents play a significant role in shaping patent law and its application.

Hyatt v. United States Patent and Trademark Office

This case highlights the complexities of patent application processes, particularly in managing multiple claims and the implications of changes in patent law over time. It underscores the importance of adhering to regulatory requirements and the potential consequences of non-compliance[2].

Small Claims Patent Court

The concept of a small claims patent court, although not directly related to Patent 3,666,858, is an interesting development in the patent landscape.

Feasibility and Structure

The Administrative Conference of the United States (ACUS) has studied the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity. This could potentially simplify the process for smaller entities to enforce their patent rights[5].

Key Takeaways

  • Patent Claims: The claims in a patent define its scope and protection.
  • Subject Matter Eligibility: Patents must integrate judicial exceptions into practical applications to be eligible.
  • Patent Landscape Analysis: This analysis helps in understanding competitors, market trends, and legal risks.
  • Legal Status and Expiry Dates: These are crucial for strategic planning and decision-making.
  • Recent Updates: The 2024 USPTO guidance update on AI patents clarifies the evaluation of AI-assisted inventions.

FAQs

What is the significance of Patent 3,666,858 in the context of current patent law?

Patent 3,666,858, although older, provides insights into the evolution of patent law and the criteria for patent eligibility. It helps in understanding how patent claims were structured and evaluated in the past.

How does the 2024 USPTO guidance update on AI patents affect older patents?

The update does not directly affect older patents but provides clarity on how AI-assisted inventions are evaluated. This clarity can inform strategies for new patent applications and the interpretation of existing patents.

What is the role of patent landscape analysis in business strategy?

Patent landscape analysis helps businesses understand their competitors, identify market trends, and make informed decisions about innovation and litigation.

Why is the legal status of a patent important?

The legal status of a patent determines its enforceability and the rights it confers. Knowing whether a patent is alive, pending, lapsed, revoked, or expired is crucial for business and legal strategies.

What are the potential benefits of a small claims patent court?

A small claims patent court could simplify and reduce the costs associated with patent litigation, making it more accessible for smaller entities to enforce their patent rights.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Hyatt v. United States Patent and Trademark Office - U.S. Court of Appeals for the Federal Circuit
  3. Navigating Technological Domains with Patent Landscape Analysis - Sagacious Research
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law and Technology
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,666,858

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 3,666,858

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium 716736 ⤷  Subscribe
Cyprus 658 ⤷  Subscribe
Denmark 130949 ⤷  Subscribe
United Kingdom 1204171 ⤷  Subscribe
United Kingdom 1204172 ⤷  Subscribe
Ireland 32912 ⤷  Subscribe
Malaysia 7300112 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.